TLR4 and colorectal cancer: In this current study, TLR4 blockade using neutralizing antibody alleviated HM-inhibited ERK phosphorylation, demonstrating that HM acts partially through TLR4 and suggesting the presence of other HM receptors in colorectal cancer cells.